1. Clinical Overview
A fixed-dose combination (FDC) therapy for the management of moderate to severe allergic respiratory conditions, particularly bronchial asthma and allergic rhinitis. It provides a triple-action approach: Montelukast is a leukotriene receptor antagonist (LTRA) that reduces bronchoconstriction and inflammation; Levocetirizine is a potent second-generation H1-antihistamine that blocks histamine-mediated allergic symptoms; Acebrophylline is a mucolytic and bronchodilator that improves airway clearance and reduces bronchial hyperreactivity. This combination is widely used in the Indian context for its synergistic effect in controlling both upper and lower airway allergic inflammation.
| Onset | Duration | Bioavailability |
|---|---|---|
| Levocetirizine: ~1 hour; Montelukast: ~3-4 hours for peak effect; Acebrophylline: ~1-2 hours. | Levocetirizine: ~24 hours; Montelukast: ~24 hours; Acebrophylline: ~8-12 hours. | Montelukast: ~64% (oral); Levocetirizine: >95% (oral); Acebrophylline: ~70-80% (oral). |
2. Mechanism of Action
The combination exerts a synergistic effect on the allergic-inflammatory cascade in the respiratory tract. Montelukast selectively blocks the cysteinyl leukotriene type 1 (CysLT1) receptor, inhibiting the action of leukotrienes (LTC4, LTD4, LTE4) which are potent mediators of bronchoconstriction, vascular permeability, and eosinophil recruitment. Levocetirizine is a potent and selective peripheral H1-receptor inverse agonist, preventing histamine-induced symptoms like itching, sneezing, and rhinorrhea. Acebrophylline has a dual action: it acts as a mucolytic by reducing mucus viscosity and secretion, and its metabolite, theophylline, acts as a bronchodilator via non-selective phosphodiesterase (PDE) inhibition and adenosine receptor antagonism, reducing airway hyperresponsiveness.
3. Indications & Uses
- Prophylaxis and chronic treatment of Bronchial Asthma (including aspirin-sensitive and exercise-induced bronchoconstriction)
- Symptomatic treatment of Perennial and Seasonal Allergic Rhinitis
- Management of Chronic Obstructive Pulmonary Disease (COPD) with reversible airway component and mucus hypersecretion
4. Dosage & Administration
Adult Dosage: One tablet (Montelukast 10mg + Levocetirizine 5mg + Acebrophylline 200mg) once daily, preferably in the evening. For allergic rhinitis, can be taken in the morning if nocturnal symptoms are not a concern.
Administration: Administer orally with or without food. Swallow the tablet whole with a glass of water. Do not crush or chew. For optimal control of nocturnal asthma symptoms, evening dosing is preferred. Maintain adequate hydration.
5. Side Effects
Common side effects may include:
- Headache
- Drowsiness/Somnolence (due to Levocetirizine)
- Dry mouth
- Fatigue
- Nausea
- Abdominal pain
- Throat irritation
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Rifampicin | Significantly decreases Montelukast plasma levels (CYP inducer). May reduce efficacy. | Major |
| Phenobarbital, Phenytoin, Carbamazepine | Induce CYP enzymes, reducing Montelukast and Theophylline levels. | Major |
| Cimetidine, Ciprofloxacin, Erythromycin, Fluvoxamine | Inhibit CYP1A2/CYP3A4, increasing Theophylline (from Acebrophylline) levels, risk of toxicity. | Major |
| Warfarin | Theophylline may potentiate anticoagulant effect; monitor INR. | Moderate |
| Beta-blockers (non-selective like Propranolol) | Antagonistic bronchodilator effect; may precipitate bronchospasm. | Moderate |
| Diuretics (especially Loop diuretics) | Synergistic hypokalemic effect with Theophylline, increasing risk of arrhythmias. | Moderate |
| Alcohol & CNS Depressants | Potentiates sedative effect of Levocetirizine. | Moderate |
| Other Anticholinergic drugs | Increased risk of urinary retention and dry mouth with Levocetirizine. | Moderate |
7. Patient Counselling
- DO take the medication exactly as prescribed, usually once daily.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DO maintain adequate fluid intake unless contraindicated.
- DO inform all your doctors about all medications you are taking, including OTC drugs and herbal supplements.
- DONT use this medication to treat an acute asthma attack. Always keep your rescue inhaler (e.g., Salbutamol) handy.
- DONT crush, chew, or break the tablet.
- DONT double the dose if you miss one. Take the next dose at the regular time.
- DONT stop taking this medicine suddenly without consulting your doctor, even if you feel better.
8. Toxicology & Storage
Overdose: Symptoms may be an extension of side effects: Severe drowsiness, agitation, restlessness, insomnia, nausea, vomiting, tachycardia, cardiac arrhythmias, tremors, seizures (especially from theophylline), and in extreme cases, status epilepticus and cardiorespiratory arrest.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep in the original blister pack or container. Keep out of reach of children. Do not use after the expiry date printed on the pack.